Search Results 771-780 of 17214 for treatment resistant depression
The purpose of Phase I of this study is to evaluate the safety and tolerability of CTX-712 in patients with relapsed/refractory (R/R) acute myeloid leukemia ( ...
... Resistant to Treatment Scottsdale/Phoenix, AZ; Rochester, MN. The purpose of ... treatment (refractory). Monoclonal antibodies, such as rituximab, may ...
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies · Share · Facebook · Twitter.
PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer. A Study ...
About this study. The purpose of this 3-part study, comprising a phase 1b dose escalation, dose expansion, and a phase 2, is to assess the safety, ...
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
... treatment with mTOR inhibitors sirolimus or everolimus as part of their clinical care. ... Post Approval Study for Treatment of Drug-resistant Adult Primary FSGS ...
In addition to having chronic pain, some people have depression or anxiety. Psychologists provide group-based cognitive behavioral treatments and if ...
... depression and anxiety. It has also been proposed ... This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy ...
This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult patients with Relapsed or Refractory NHL. The trial will be ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift now to help create new and better solutions for the more than 1.3 million patients who turn to Mayo Clinic each year.